ePRO Consortium Welcomes Medable C-Path is proud to welcome Medable, Inc as the newest member of its Electronic Patient-Reported Outcome Consortium. Compr
C-Path Selects Arizona Financial Leader, former U.S. Embassy Finance Director, as CFO TUCSON, Ariz., August 18, 2021— Critical Path Institute (C-Path) is pleased to announce that it has selected Kevin Perkins as it
Celebrating National Nonprofit Day and Sharing C-Path Updates As we observe National Nonprofit Day and recognize the invaluable effort nonprofits put towards making an impact in our communitie
August 7, 2021 Antenatal and perinatal factors influencing neonatal blood pressure: a systematic review
September 14, 2021 VIEW NOW | 2021 RDCA-DAP® Workshop The Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®) is an FDA-funded initiative with the goal of accelerat
C-Path Appoints Clinical Outcome Assessment Expert as New Executive Director Sonya Eremenco will lead C-Path’s PRO Consortium TUCSON, Ariz., August 5, 2021— Critical Path Institute (C-Path) announced it
August 25, 2021 WEBINAR | Alternative Solutions in Safety Assessment When: August 25, 2021, 10 – 11:30 a.m. ET C-Path’s Predictive Safety Testing Consortium (PSTC) invites you to this free webi
August 1, 2021 A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson’s Disease in Participants With Leucine-Rich Repeat Kinase 2 Mutation Ahamadi M, Mehrotra N, Hanan N, Lai Yee K, Gheyas F, Anton J, Bani M, Boroojerdi B, Smit H, Weidemann J, Macha S, Thuillier V...
Digital Health Technologies Hold Key to New Parkinson’s Treatments Global stakeholders come together to collaborate with urgency to address unmet needs for Parkinson’s therapies. TUCSON, Ariz., J
Launch of UNITE4TB Partnership Marks a New Era in Tuberculosis Treatment Development The partnership will accelerate the development of new Tuberculosis (TB) drug regimens as part of the Innovative Medicines Initiat